首页> 美国卫生研究院文献>Thrombosis Journal >The genetic variation rs6903956 in the novel androgen-dependent tissue factor pathway inhibitor regulating protein (ADTRP) gene is not associated with levels of plasma coagulation factors in the Singaporean Chinese
【2h】

The genetic variation rs6903956 in the novel androgen-dependent tissue factor pathway inhibitor regulating protein (ADTRP) gene is not associated with levels of plasma coagulation factors in the Singaporean Chinese

机译:新的雄激素依赖性组织因子途径抑制剂调节蛋白(ADTRP)基因的遗传变异rs6903956与新加坡华人的血浆凝血因子水平无关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundGenome-wide association study (GWAS) has reported that rs6903956 within the first intron of androgen-dependent tissue factor pathway inhibitor (TFPI) regulating protein (ADTRP) gene is associated with coronary artery disease (CAD) risk in the Chinese population. Although ADTRP is believed to be involved in the upregulation of TFPI, the underlying mechanism involved is largely unknown. This study investigated the association of rs6903956 with plasma Factor VII coagulant activity (FVIIc) and fibrinogen levels, which are regulated by TFPI and are independent risk predictors for CAD.
机译:背景全基因组关联研究(GWAS)报告说,中国人群中雄激素依赖性组织因子途径抑制剂(TFPI)调节蛋白(ADTRP)基因的第一个内含子中的rs6903956与冠心病(CAD)风险相关。尽管ADTRP被认为与TFPI的上调有关,但所涉及的潜在机制很大程度上未知。这项研究调查了rs6903956与血浆VII因子凝血活性(FVIIc)和纤维蛋白原水平的相关性,这些因子受TFPI调节并且是CAD的独立危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号